SCHEMBL8400430

SCHEMBL8400430

CSc1n[nH]c(-c2cccnc2)n1

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DCUN1D1 Q96GG9 2/20 0.68
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C19 P33261 1/20 0.56
HPGD P15428 2/20 0.55
LMNA P02545 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
MAPT P10636 1/20 0.52
NPC1 O15118 2/20 0.51
POLB P06746 2/20 0.51
KDM4E B2RXH2 1/20 0.51
RAB9A P51151 1/20 0.51
ATM Q13315 1/20 0.51
BTK Q06187 1/20 0.49
ALPL P05186 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7635074 0.80 DCUN1D1 (0.71) DCUN1D1HPGDLMNASMN1; SMN2MAPT
SCHEMBL2629350 0.78 SMN1; SMN2 (0.58) CYP1A2CYP3A4CYP2C19HPGDLMNA
SCHEMBL11598851 0.76 SMN1; SMN2 (0.87) CYP1A2CYP3A4HPGDLMNASMN1; SMN2
SCHEMBL5787498 0.75 ALDH1A1 (0.65) CYP1A2CYP3A4LMNASMN1; SMN2MAPT
SCHEMBL1233176 0.75 SMN1; SMN2 (0.58) CYP1A2CYP3A4CYP2C19HPGDSMN1; SMN2
SCHEMBL2251043 0.73 SMN1; SMN2 (0.87) CYP1A2CYP3A4CYP2C19HPGDLMNA
SCHEMBL25957505 0.73 DCUN1D1 (0.66) DCUN1D1NPC1POLBKDM4ERAB9A
SCHEMBL16661201 0.73 DCUN1D1 (0.57) DCUN1D1CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL17280142 0.72 SMN1; SMN2 (0.73) HPGDSMN1; SMN2MAPTNPC1RAB9A
SCHEMBL15452340 0.72 SMN1; SMN2 (0.73) LMNASMN1; SMN2NPC1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36374-E 1,2,3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists H. LUNDBECK, A/S (DK) 1999-11-02 US disclosed
EP-0296721-B1 HETEROCYCLIC COMPOUNDS H. LUNDBECK A/S (DK) 1993-06-23 EP disclosed
US-4925858-A NERVOUS SYSTEM DISORDERS, ALZHEIMER*S DISEASE H. LUNDBECK A/S (DK) 1990-05-15 US disclosed
US-4866077-A TREATMENT OF NERVOUS SYSTEM DISORDERS SUCH AS ALZHEIMER*S DISEASE H. LUNDBECK A/S (DK) 1989-09-12 US disclosed
EP-0296721-A2 Heterocyclic compounds H. LUNDBECK A/S (DK) 1988-12-28 EP disclosed